- Student Records
Programme & Unit Catalogues


PA20298: Evidence based practice

Follow this link for further information on academic years Academic Year: 2014/5
Further information on owning departmentsOwning Department/School: Department of Pharmacy & Pharmacology
Further information on credits Credits: 3
Further information on unit levels Level: Intermediate (FHEQ level 5)
Further information on teaching periods Period: Semester 1
Further information on unit assessment Assessment Summary: EX 100%
Further information on unit assessment Assessment Detail:
  • Examination (EX 100%)
Further information on supplementary assessment Supplementary Assessment: Like-for-like reassessment (where allowed by programme regulations)
Further information on requisites Requisites: Before taking this unit you must take PA10014
Further information on descriptions Description: Aims:
To provide students with an understanding of decision making in health care, including the assessment and interpretation of risk, benefit-risk considerations, and health care planning both at a population level and at the level of individual patients.

Learning Outcomes:
After completing this unit, students should be able to:
* Demonstrate and apply knowledge of how benefits and risks of medicine use are assessed, both at the level of individual patients and at the level of populations.
* Critically appraise and interpret publications regarding pre and post-marketing evaluations of risks and benefits of medicines.
* Identify patient and prescription problems and propose suitable solutions.

Skills:
Analytical skills, critical thinking, risk assessment and decision making. All these skills are taught, facilitated and assessed.

Content:
Spontaneous reporting and pharmacoepidemiology: introduction to the principles and methods of signal generation and evaluation in postmarketing safety assessment of medicines.
Critical appraisal: introduction to critical appraisal of randomised controlled clinical trials, case control studies, cohort studies and pharmacoeconomics analyses.
Clinical pharmacy: introduction to clinical pharmacy, risk assessment in health care planning, drug- and disease monitoring, and medication errors.
Pharmacoeconomics: introduction to the principles of health economics.
Throughout this module, the students will use a range of aspects from these four areas and apply them to different scenarios in clinical practice.
Further information on programme availabilityProgramme availability:

PA20298 is a Designated Essential Unit on the following programmes:

Department of Pharmacy & Pharmacology
Notes:
* This unit catalogue is applicable for the 2014/15 academic year only. Students continuing their studies into 2015/16 and beyond should not assume that this unit will be available in future years in the format displayed here for 2014/15.
* Programmes and units are subject to change at any time, in accordance with normal University procedures.
* Availability of units will be subject to constraints such as staff availability, minimum and maximum group sizes, and timetabling factors as well as a student's ability to meet any pre-requisite rules.